The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers

NCT04019652 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Mineralocorticoid Receptor Antagonist

Interventions

DRUG: CS-3150
DRUG: Moxifloxacin
DRUG: Placebo matching moxifloxacin tablet
DRUG: Placebo matching CS-3150

Sponsor

Daiichi Sankyo